Zhejiang Haisen Pharmaceutical Co., Ltd.
FDA inspection history in Dongyang, China, 2018
- 1
- Form 483
Every document, by year
- Form 483
2018: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2018One Form 483, at Dongyang, China.
Cited most
Across all Zhejiang Haisen Pharmaceutical Co. observations on file
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.198Complaint files1
The complete Zhejiang Haisen Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Dongyang, China
One Form 483 · 2018 · 2 observations
Latest: Form 483, Apr 11, 2018 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2018-04-11 | 483 Form 483 | Dongyang, China | 2 | $99 |
Investigators on these documents
FEI number 3003967524 · most recent document Apr 11, 2018
About Zhejiang Haisen Pharmaceutical Co., Ltd.
How many FDA Form 483s has Zhejiang Haisen Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Zhejiang Haisen Pharmaceutical Co., Ltd.; the most recent is dated Apr 11, 2018.
When was Zhejiang Haisen Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Zhejiang Haisen Pharmaceutical Co., Ltd. is a Form 483 dated Apr 11, 2018, for the site in Dongyang, China.
What did FDA cite at Zhejiang Haisen Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Zhejiang Haisen Pharmaceutical Co., Ltd. are 21 CFR 211.194 (Laboratory records), 1 time; 21 CFR 211.198 (Complaint files), 1 time.